drops

Following updates to prescribing information on pilocarpine 1.25% and release of the ASCRS Consensus Statement on the topic, several members of the ASCRS leadership sat down to discuss presbyopia-correcting drops. Sumit “Sam” Garg, MD, EyeWorld Chief Medical Editor, led a discussion with Elizabeth Yeu, MD, Cathleen McCabe, MD, and Douglas Rhee, MD. They addressed some of the reported adverse events, how to examine and speak to patients about the product, uses of pilocarpine in the glaucoma field, and more.